Home>Topics>>FDA clears Beleodaq

FDA clears Beleodaq

SeekingAlpha.com: SA Currents

Thu, 3 Jul 2014

The FDA approves Spectrum Pharmaceuticals' ( SPPI +4.9% ) Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma (PTCL) who have relapsed or who are refractory to previous treatment. This is the third drug the agency has cleared since 2009 for the treatment of PTCL. It ...
Content Partners